Abdun-Nabi Daniel

CIK 00013801873 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001380187

Recent Transactions

50 trades

Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2026-08-06−400→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2026-08-06+400→ 400 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2025-08-06+7,200→ 7,200 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2025-07-17−1→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2025-07-17+1→ 1 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-07-17+925→ 925 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2024-06-02+81→ 277 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-06-02−81→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-06-01−7→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2024-06-01+7→ 196 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2023-08-09+3,571→ 8,339 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2023-08-09−3,571→ 0 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2023-06-02+3,571→ 3,571 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2023-06-01+297→ 4,768 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2023-06-01−297→ 298 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2022-08-09+3,571→ 3,571 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2022-06-01−298→ 595 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2022-06-01+298→ 8,108 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2021-06-04+10,000→ 10,000 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2021-06-01+893→ 893 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2021-06-01+2,678→ 2,678 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−892→ 0 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−1,785→ 0 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−1,339→ 0 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27+1,322→ 1,322 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27+170→ 170 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-02+3,571→ 3,571 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2020-05-29+10,000→ 10,000 total
Purchase
Aptevo Therapeutics Inc.$APVO
Common Stock
2019-06-25$0.90/sh+16,667→ 109,351 total
Award
Aptevo Therapeutics Inc.$APVO
Option (right to buy)
2019-06-01+25,000→ 25,000 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2019-05-31+10,000→ 10,000 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2019-03-04$58.11/sh−14,565→ 142,617 total
Tax Payment
Emergent BioSolutions Inc.$EBS
Common Stock
2019-02-28$58.71/sh−5,101→ 157,182 total
Tax Payment
Emergent BioSolutions Inc.$EBS
Common Stock
2019-02-27$57.98/sh−2,570→ 162,283 total
Tax Payment
Emergent BioSolutions Inc.$EBS
Common Stock
2019-02-26$61.01/sh−1,714→ 164,853 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2018-09-17$65.00/sh−1,319→ 166,567 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Stock Option (Right to Buy)
2018-09-17+1,319→ 0 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Common Stock
2018-09-17$13.38/sh+1,319→ 167,886 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2018-09-14$65.00/sh−28,220→ 166,567 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Stock Option (Right to Buy)
2018-09-14+28,220→ 1,319 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Common Stock
2018-09-14$13.38/sh+28,220→ 194,787 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2018-09-05$59.49/sh−30,776→ 166,567 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Common Stock
2018-09-04$13.38/sh+60,000→ 257,343 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Stock Option (Right to Buy)
2018-09-04−60,000→ 29,539 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2018-09-04$60.54/sh−60,000→ 197,343 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2018-06-05$52.11/sh−15,785→ 197,343 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2018-06-01+25,000→ 25,000 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-05-25+12,500→ 12,500 total
Tax Payment
Emergent BioSolutions Inc.$EBS
Common Stock
2018-03-09$51.84/sh−7,825→ 213,128 total
Tax Payment
Emergent BioSolutions Inc.$EBS
Common Stock
2018-02-28$49.97/sh−6,599→ 220,953 total

Companies

Recent Filings

Address

2401 4TH AVENUE SUITE 1050

SEATTLE, WA, 98121

View on SEC.gov